SANTA MONICA, Calif. & SAN DIEGO--(BUSINESS WIRE)--GoodRx (NASDAQ: GDRX), a leading resource for healthcare savings and information, and MedImpact, the independent pharmacy benefit manager (PBM) and ...
GoodRx addresses many challenges in the U.S. healthcare space. GoodRx's tech-enabled solutions are proving to be an immense value-add as their platforms have built great trust with their consumers.
GoodRx to collaborate with Eli Lilly to expand employer-sponsored access to Zepbound® KwikPen®, an FDA-approved dual GIP and GLP-1 obesity treatment Through GoodRx Employer Direct, self-insured ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results